Mpox: epidemiology, clinical manifestations and recent developments in treatment and prevention

Selvaraj, Nikil; Shyam, Shreya; Dhurairaj, Puvin; Thiruselvan, Kaviarasan; Thiruselvan, Akil; Kancherla, Yochana; Kandamaran, Pritika

doi:10.1080/14787210.2023.2208346

Cited by 2 publications

(2 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Investigations on wild animals in Wisconsin and Illinois after the US outbreak in 2003 failed to uncover any such evidence, and none of the affected human transmitted the illness. 34 On the contrary, the 300 of the diseased animals and the exposed prairie dogs from Ghana were never located. Scientists deliberately infected a wide variety of lab animals including guinea pig, hamster and rabbit with no corroborating finding.…”

Section: Zoonosis Of Mpox Virusmentioning

confidence: 99%

“…On 24 May 2023, the European Food Safety Authority observed that there was no reported affected pet or wild animal outside Africa. Investigations on wild animals in Wisconsin and Illinois after the US outbreak in 2003 failed to uncover any such evidence, and none of the affected human transmitted the illness 34 . On the contrary, the 300 of the diseased animals and the exposed prairie dogs from Ghana were never located.…”

Section: Zoonosis Of Mpox Virusmentioning

confidence: 99%

See 1 more Smart Citation

Transmission dynamics, complications and mitigation strategies of the current mpox outbreak: A comprehensive review with bibliometric study

Mohapatra,

Singh,

Branda

et al. 2024

Reviews in Medical Virology

View full text Add to dashboard Cite

As the mankind counters the ongoing COVID‐19 pandemic by the novel severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), it simultaneously witnesses the emergence of mpox virus (MPXV) that signals at global spread and could potentially lead to another pandemic. Although MPXV has existed for more than 50 years now with most of the human cases being reported from the endemic West and Central African regions, the disease is recently being reported in non‐endemic regions too that affect more than 50 countries. Controlling the spread of MPXV is important due to its potential danger of a global spread, causing severe morbidity and mortality. The article highlights the transmission dynamics, zoonosis potential, complication and mitigation strategies for MPXV infection, and concludes with suggested ‘one health’ approach for better management, control and prevention. Bibliometric analyses of the data extend the understanding and provide leads on the research trends, the global spread, and the need to revamp the critical research and healthcare interventions. Globally published mpox‐related literature does not align well with endemic areas/regions of occurrence which should ideally have been the scenario. Such demographic and geographic gaps between the location of the research work and the endemic epicentres of the disease need to be bridged for greater and effective translation of the research outputs to pubic healthcare systems, it is suggested.

show abstract

Section: Zoonosis Of Mpox Virusmentioning

confidence: 99%

Section: Zoonosis Of Mpox Virusmentioning

confidence: 99%